Luzifine Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Luzifine Cream is effective against a broad spectrum of dermatophytes such as Trichophyton rubrum and Trichophyton mentagrophytes, as well as Candida species and Malassezia furfur. The cream is intended for external use and should be applied once daily to the affected area and surrounding skin after cleansing and drying. Treatment duration varies depending on the infection type but typically ranges from one to two weeks. Patients should be advised to avoid contact with eyes and mucous membranes and to discontinue use if irritation or hypersensitivity occurs. Luzifine Cream offers a convenient and well-tolerated option for managing superficial fungal infections, promoting rapid symptom relief and resolution of lesions. It is contraindicated in individuals with known hypersensitivity to luliconazole or any cream excipients.